These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 24809463)

  • 1. Clozapine safety, 40 years later.
    Raja M; Raja S
    Curr Drug Saf; 2014; 9(3):163-95. PubMed ID: 24809463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clozapine safety, 35 years later.
    Raja M
    Curr Drug Saf; 2011 Jul; 6(3):164-84. PubMed ID: 22122392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association study of the HTR2C, leptin and adiponectin genes and serum marker analyses in clozapine treated long-term patients with schizophrenia.
    Klemettilä JP; Kampman O; Seppälä N; Viikki M; Hämäläinen M; Moilanen E; Mononen N; Lehtimäki T; Leinonen E
    Eur Psychiatry; 2015 Feb; 30(2):296-302. PubMed ID: 25284335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review and management of clozapine side effects.
    Miller DD
    J Clin Psychiatry; 2000; 61 Suppl 8():14-7; discussion 18-9. PubMed ID: 10811238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and side-effects of clozapine not associated with variation in the 5-HT2C receptor.
    Rietschel M; Naber D; Fimmers R; Möller HJ; Propping P; Nöthen MM
    Neuroreport; 1997 May; 8(8):1999-2003. PubMed ID: 9223092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guide to the Management of Clozapine-Related Tolerability and Safety Concerns.
    Citrome L; McEvoy JP; Saklad SR
    Clin Schizophr Relat Psychoses; 2016; 10(3):163-177. PubMed ID: 27732102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Termination of clozapine treatment due to medical reasons: when is it warranted and how can it be avoided?
    Nielsen J; Correll CU; Manu P; Kane JM
    J Clin Psychiatry; 2013 Jun; 74(6):603-13; quiz 613. PubMed ID: 23842012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphisms of the leptin and HTR2C genes and clozapine-induced weight change and baseline BMI in patients with chronic schizophrenia.
    Kang SH; Lee JI; Han HR; Soh M; Hong JP
    Psychiatr Genet; 2014 Dec; 24(6):249-56. PubMed ID: 25304226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HTR2C polymorphisms, olanzapine-induced weight gain and antipsychotic-induced metabolic syndrome in schizophrenia patients: a meta-analysis.
    Ma X; Maimaitirexiati T; Zhang R; Gui X; Zhang W; Xu G; Hu G
    Int J Psychiatry Clin Pract; 2014 Oct; 18(4):229-42. PubMed ID: 25152019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A systematic review of sex-based differences in effectiveness and adverse effects of clozapine.
    Alberich S; Fernández-Sevillano J; González-Ortega I; Usall J; Sáenz M; González-Fraile E; González-Pinto A
    Psychiatry Res; 2019 Oct; 280():112506. PubMed ID: 31401291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 759C/T genetic variation of 5HT(2C) receptor and clozapine-induced weight gain.
    Basile VS; Masellis M; De Luca V; Meltzer HY; Kennedy JL
    Lancet; 2002 Nov; 360(9347):1790-1. PubMed ID: 12480467
    [No Abstract]   [Full Text] [Related]  

  • 12. A Focused Review of the Metabolic Side-Effects of Clozapine.
    Yuen JWY; Kim DD; Procyshyn RM; Panenka WJ; Honer WG; Barr AM
    Front Endocrinol (Lausanne); 2021; 12():609240. PubMed ID: 33716966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A review of clozapine safety.
    Fitzsimons J; Berk M; Lambert T; Bourin M; Dodd S
    Expert Opin Drug Saf; 2005 Jul; 4(4):731-44. PubMed ID: 16011451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CoMET: a protocol for a randomised controlled trial of co-commencement of METformin as an adjunctive treatment to attenuate weight gain and metabolic syndrome in patients with schizophrenia newly commenced on clozapine.
    Siskind D; Friend N; Russell A; McGrath JJ; Lim C; Patterson S; Flaws D; Stedman T; Moudgil V; Sardinha S; Suetani S; Kisely S; Winckel K; Baker A
    BMJ Open; 2018 Mar; 8(3):e021000. PubMed ID: 29500217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pronounced early increase in circulating leptin predicts a lower weight gain during clozapine treatment.
    Monteleone P; Fabrazzo M; Tortorella A; La Pia S; Maj M
    J Clin Psychopharmacol; 2002 Aug; 22(4):424-6. PubMed ID: 12172344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Side effect profiles of new antipsychotic agents.
    Casey DE
    J Clin Psychiatry; 1996; 57 Suppl 11():40-5; discussion 46-52. PubMed ID: 8941170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A naturalistic comparison of the long-term metabolic adverse effects of clozapine versus other antipsychotics for patients with psychotic illnesses.
    Kelly AC; Sheitman BB; Hamer RM; Rhyne DC; Reed RM; Graham KA; Rau SW; Gilmore JH; Perkins DO; Peebles SS; VanderZwaag CJ; Jarskog LF
    J Clin Psychopharmacol; 2014 Aug; 34(4):441-5. PubMed ID: 24943389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological and behavioral management of some often-overlooked clozapine-induced side effects.
    Sagy R; Weizman A; Katz N
    Int Clin Psychopharmacol; 2014 Nov; 29(6):313-7. PubMed ID: 24932886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacogenetics of leptin in antipsychotic-associated weight gain and obesity-related complications.
    Lee AK; Bishop JR
    Pharmacogenomics; 2011 Jul; 12(7):999-1016. PubMed ID: 21787190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The safety of clozapine in the elderly.
    Gareri P; De Fazio P; Russo E; Marigliano N; De Fazio S; De Sarro G
    Expert Opin Drug Saf; 2008 Sep; 7(5):525-38. PubMed ID: 18759705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.